M. W. Saif, “MM-398 Achieves Primary Endpoint of Overall Survival in Phase III Study in Patients with Gemcitabine Refractory Metastatic Pancreatic Cancer”, JOP. J Pancreas (Online), vol. 15, no. 3, pp. 278–279, May 2014.